- Consumer Products
- Latest 71.01
- Currency US$
- Change 0.32
- Percent Change 0.453 %
- Volume 1,187,868
- Thu May 23, 2013 3:13 PM EDT NASDAQ data delayed 15 minutes.
12 months ended Mar 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Apr 22||$0.38||Jul 23||$0.39|
12 months ended May 23, 2013.
A look at major corporate events and financial announcements that are coming up.
About the Company
Illumina Inc. is a leading developer of next-generation tools for the large-scale analysis of genetic variation and function. The company's tools will provide information that could be used to improve drugs and therapies, customize diagnoses and treatment, and cure disease. The company is developing a comprehensive line of products that can address the scale of experimentation and the breadth of functional analysis required to achieve the goals of molecular medicine.